Navigation Links
Roche Women Honored as 2010 TWIN Awardees
Date:5/4/2010

e joined Pharma Partnering as director of Global Business Development for Virology. A year later, her roles was expanded to include the therapeutic areas of inflammation, respiratory and anti-infectives. Dr. Graves is the author of several publications and presentations. She earned her BSc in Chemistry with Honors from Tennessee Tech University and her Ph.D. in Chemistry from University of North Carolina, Chapel Hill. She also served as a National Institutes of Health (NIH) Postdoctoral Fellow in the Department of Biochemistry at the University of California, Berkeley.

In addition to her work with Roche, Dr. Graves is devoted to her family, including husband Brad, a senior research leader at Roche, and three children Daniel, 27, Catherine, 23, and Alex, 17.  

"I feel honored to be selected for the TWIN award, and to join the outstanding group of women who have made significant contributions to our company and the health of millions.  At Roche,  I've been fortunate to able to pursue different career paths, all leading to the rewarding outcome of finding and getting new medicines to patients," she said.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employ
'/>"/>

SOURCE Roche
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... A new poll finds little support for privatizing ... insurance program for older Americans needs major changes if ... Recently Medicare,s trustees indicated that funding to ... an estimated 45 million Americans 65 and older, could ...
... June 13, 2011 Enox Biopharma, Inc., a leader ... with medical devices, today announced that it has received ... application entitled "Device and Method for Administering Therapeutic Agents" ... Enox acquired this patent from its ...
Cached Medicine Technology:Little Support for GOP Plan to Privatize Medicare: Poll 2Little Support for GOP Plan to Privatize Medicare: Poll 3Little Support for GOP Plan to Privatize Medicare: Poll 4Little Support for GOP Plan to Privatize Medicare: Poll 5Little Support for GOP Plan to Privatize Medicare: Poll 6Little Support for GOP Plan to Privatize Medicare: Poll 7Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices 2
(Date:5/18/2013)... a few extra cups of coffee each month might ... known as primary sclerosing cholangitis (PSC), a new study ... Minn., found that drinking coffee was associated with a ... to cirrhosis of the liver, liver failure and biliary ... relationship. "While rare, PSC has extremely detrimental ...
(Date:5/18/2013)... The use of a smartphone application significantly improves ... research presented today at Digestive Disease Week (DDW). ... of the procedure, includes dietary restrictions and requires ... strict intervals. The better the preparation, the easier ... precancerous polyps in the colon. The study, which ...
(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Assisted ... it comes to safety and comfort of their ... and provides clients with an effective and cost-efficient ... This is an integrated, turnkey communications solution that ... while allowing residents independence and privacy. , ...
(Date:5/18/2013)... City, Utah (PRWEB) May 18, 2013 ... information on insurance agents’ role in Marketplaces ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... of Health and Human Services (HHS) recently released ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4
... Georgetown University Medical Center (GUMC) has licensed worldwide rights ... "theranostic," to BioMetrx, LLC. The agent was invented ... with BioMetrx, LLC, a Maryland-headquartered biotechnology company, expedites the ... the clinical setting for further investigation as a potential ...
... Serena Gordon HealthDay Reporter , MONDAY, Jan. 23 ... in 1973, opponents have questioned the safety of medical procedures ... that having a legal abortion is safer than carrying a ... a full-term pregnancy and delivery is 8.8 deaths per 100,000, ...
... TUESDAY, Jan. 24 (HealthDay News) -- Baltimore is the ... new report that examined patient death and complication rates ... report identified hospitals performing in the top 5 percent ... ranked cities according to those with the highest percentage ...
... Five of the 28 scientists considered "people who, 10 ... in their countries", by the Howard Hughes Medical Institute, ... American researchers are based at the Instituto Gulbenkian de ... (ITQB), the Instituto de Medicina Molecular (IMM) and the ...
... BROOK, Ill. Preoperative MRI helps surgeons make more ... cancer, according to a new study published online in ... prostate cancer is the most common cancer diagnosed in ... and Prevention. Open radical prostatectomy, or removal of the ...
... Physician referral rates in the United States doubled between 1999 and ... the rising costs of health care. The increase ... as Type 2 diabetes. The results are staggering: over the same ... referral increased 159 per cent, from 40.6 million to 105 million. ...
Cached Medicine News:Health News:Georgetown University Medical Center licenses 'theranostic' for development 2Health News:Abortion Safer for Women Than Childbirth, Study Claims 2Health News:Abortion Safer for Women Than Childbirth, Study Claims 3Health News:Baltimore Deemed U.S. City With Most Top-Ranked Hospitals 2Health News:Portuguese science scores high with American funder 2Health News:Portuguese science scores high with American funder 3Health News:Preoperative MRI may reduce risk of nerve damage in prostate cancer surgeries 2Health News:Rate of physician referrals nearly doubled 2
... System is a fully automated, upgradable platform ... blood parameters in addition to comprehensive on-board ... basic blood gas model to be quickly ... and CO-oximetry in a single unit. This ...
Microcomputer controlled, preparative ultracentrifuge, with CFC-free refrigeration system. Available either internally cooled or with external water cooling. Quikset user interface, Softspin automati...
... SE Micro-ultra centrifuge continues to raise the ... now with 1,048,000 x g performance and ... DiscoveryTMM150SE processes sample sizes from 0.2 ml ... footprint, brushless direct drive, very quiet operation, ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
Medicine Products: